Josh Brumm

Overview

Josh Brumm received an average of $5M in total compensation, including $627K in salary, at Dyne Therapeutics between 2022 and 2023.

Source: SEC filing on April 5, 2024.

Related executives

We found five more executives who work or worked at Dyne Therapeutics.

Jonathan McNeill

Dyne Therapeutics

Chief Business Officer

Susanna High

Dyne Therapeutics

Chief Operating Officer

Joshua Brumm

Dyne Therapeutics

Chief Executive Officer

Oxana Beskrovnaya

Dyne Therapeutics

Chief Scientific Officer

Romesh Subramanian

Dyne Therapeutics

Chief Scientific Officer

News

You may also like